Diabetes Drug Fuels Dangerous Weight Loss Trend

A type 2 diabetes medication approved in Japan is now being sought by young individuals for rapid weight loss, a growing concern amplified by social media promotion. Doctors are issuing warnings about the serious health risks associated with this off-label use.

Many users acquire the drug, like Mounjaro, online through limited consultations. These individuals often face intense pressure regarding their appearance, particularly those in appearance-focused professions. Some have reported severe adverse effects, including nausea, depression, and significant appetite loss, prompting a 22-year-old to cease use after one injection.

Experts emphasize that off-label use may disqualify individuals from seeking support through the Relief Services for Adverse Health Effects system. Pharmaceutical companies have reiterated that the drug's safety and effectiveness are unconfirmed outside of diabetes treatment. This trend reflects a societal obsession with thinness, with a recent survey indicating a significant number of young women are underweight.

Societal pressures to be thin are being linked to health problems. Experts suggest educational initiatives in schools to promote healthy body image and an appreciation for diverse body types. There is a growing recognition of the need to address the distorted perceptions often presented on social media and in mainstream media.